Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular care, today highlighted a new post hoc analysis of aspirin use in REDUCE-IT® reinforcing that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback